Thrombopoietin (Tpo) is a glycoprotein growth factor that supports hematopoietic stem cell survival and expansion and is the principal regulator of megakaryocyte growth and differentiation. Several small, nonpeptidyl molecules have been identified as selective human Tpo receptor (hTpoR) agonists. To understand how the small molecule Tpo mimic SB394725 interacts and activates hTpoR, we performed receptor domain swap and mutagenesis studies. The results suggest that SB394725 interacts specifically with the extracellular juxtamembrane region (JMR) and the transmembrane (TM) domain of hTpoR. Solution and solid-state NMR structural studies using a peptide containing the JMR-TM sequences showed that this region of hTpoR, unexpectedly, consists of two ␣-helices separated by a few nonhelical residues. SB394725 interacts specifically with His-499 in the TM domain and a few distinct residues in the JMR-TM region and affects several specific C-terminal TM domain residues. The unique structural information provided by these studies both sheds light on the distinctive mechanism of action of SB394725 and provides valuable insight into the mechanism of ligand-induced cytokine receptor activation.
Thrombopoietin (Tpo)
2 is the primary regulator of megakaryocyte growth and differentiation to platelets (1) (2) (3) . Binding of Tpo to Tpo receptor (TpoR) triggers activation of the cytoplasmic tyrosine kinases JAK2 and TYK2, which in turn results in the activation of STAT5, phosphatidylinositol 3-kinase, and the mitogen-activated protein kinase signaling pathways (1) (2) (3) (4) (5) (6) . Activation of these signaling pathways results in changes in gene regulation, which are thought to promote progression of the TpoR-expression cells along the megakaryocytic pathway.
TpoR is a member of the type I cytokine receptor family, which consists of an extracellular cytokine binding domain, a single transmembrane (TM) domain and a cytoplasmic domain. TpoR is most closely related to erythropoietin receptor (EpoR) and granulocyte colony-stimulating factor receptor (G-CSFR). Considerable evidence suggests that dimerization and conformational change are the essential processes that lead to cytokine/growth factor receptor activation (7) (8) (9) (10) (11) . Structural studies of EpoR-interacting peptides with a range of activities have revealed that the dimerized EpoR extracellular domain has to be in the correct orientation for downstream signaling events to occur, indicating that receptor dimerization alone is not sufficient to drive receptor activation (12) . This is consistent with the observation that EpoR and the growth hormone receptor exist as dimerized but inactive receptors in the absence of ligands (12, 13) . EpoR dimerization in the absence of Epo is mediated mainly by its TM domain (7) . The isolated TM domain of the EpoR was shown to dimerize, suggesting that the TM domain may be involved in ligand-independent receptor dimerization (7) . In addition, the TM domain may also play a key role in mediating receptor activation, as demonstrated by the constitutively active TM domain mutants of the mouse EpoR (mEpoR), human G-CSFR (hG-CSFR), and human TpoR (hTpoR) (14 -17) .
We investigated the mechanism of action of a small molecule nonpeptidyl Tpo mimic, SB394725. SB394725 is a previously identified hTpoR-specific ligand with an unknown mechanism of action that activates Tpo signaling pathways and promotes differentiation of primary human bone marrow cells to megakaryocytes with an efficacy equivalent to that of recombinant hTpo (3) . By performing hTpoR domain swap and mutagenesis studies and using combinatorial approaches of solution and solid-state NMR, we have demonstrated that SB394725 interacts specifically with His-499 in the TM domain and a few distinct residues in the extracellular JMR and the TM domain of the hTpoR.
EXPERIMENTAL PROCEDURES
Plasmid Constructs-To generate a STAT response elementcontaining reporter construct, an oligonucleotide containing eight copies of the STAT response element from the IRF-1 gene * This research was supported by National Institutes of Health (NIH) Grant RO1GM066978 and utilized the Resource for NMR Molecular Imaging of Proteins supported by NIH Grant P41EB002031. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 1 promoter (5Ј-TGGTCCTGGGAATCTGCCTACATC-3Ј) was synthesized and cloned into the pGL2-basic vector. Full-length cDNAs of hTpoR and hG-CSFR were obtained by reverse transcription-PCR from human bone marrow RNA and cloned into the pcDNA3.1/hygro(ϩ) vector. Chimeric receptor constructs were generated by using a PCR-based bridging technique. Briefly, hTpoR and hG-CSFR cDNAs were used as templates to generate G(T)G, G(13 ϩ T)G and T(T)G constructs with a set of primers for each construct. Each primer set contained a forward primer that annealed to the sequence corresponding to the N terminus of the chimeric construct and a reverse primer that annealed to the sequence corresponding to the C terminus of the chimeric construct and a pair of bridging primers that annealed to both the sequences corresponding to the N and C termini of the constructs. The forward and reverse primers for constructs G(T)G and G(13 ϩ T)G were 5Ј-GTAAGCTTAT-GGCAAGGCTGGGAAACTGCAGC-3Ј and 5Ј-GACTCGA-GCTAGTCCCCCTGGAGCACATAGGTC T-3Ј, respectively. The forward and reverse primers for construct T(T)G were 5Ј-ACGATATCATGGTCACCTCCTGCCTCCTC-3Ј and 5Ј-AGCCTCGAGTCAAGGCTGCTGCCAATAGCT-3Ј, respectively. The bridging primers for constructs G(T)G, G(T ϩ 13)G, and T(T)G were 5Ј-CTTGACCCCAGAGGGGTCGGAGT-GGATCTCCTTGGTGACCGCTC-3Ј, 5Ј-GCCACCAACA-GTACAGTCCTCACCCTGATGACCGACCCAACTAGG-GTGGAGACC GCCACCGAGACCGCC-3Ј, and 5Ј-GTCC-TGGGCCTGCTGCTGCTGAGCCCCAACAAGAATCCC-3Ј, respectively. The resulting PCR products were purified and inserted into the HindIII and XhoI sites for constructs G(T)G and G(13 ϩ T)G and into the EcoRV and XhoI sites for construct T(T)G. Site-directed mutagenesis was performed using the QuikChange site-directed mutagenesis kit (Stratagene) as described by the manufacturer. A pair of primers containing CAC or CAT at the corresponding Leu residue was used to generate the His mutants. Primer pairs containing GCT, GCC, GCA, or GCG at the designated site for alanine substitution were used to generate mutant receptors for alanine-scanning mutagenesis study. The cDNA construct containing the hTpoR-(479 -519) peptide was generated from a pair of synthesized, codon-optimized (for Escherichia coli expression) oligomers containing the JMR-TM sequences of hTpoR from Asp-479 to Ala-519. The oligonucleotides were annealed (in 40 mM Tris-HCl, 10 mM MgCl 2 , and 50 mM NaCl) and ligated to AlwNI-digested pET31b(ϩ) vector (Novagen, Madison, WI) by using a Quick Change ligation kit (New England Biolabs). All of the constructs were confirmed by sequence analysis.
Cell Lines and Cell-based Assay-HepG2 cells were maintained in regular tissue culture-treated flasks. Cells were routinely passed through a 21G1 gauge needle twice to break apart the multicell aggregates during cell passage. The various chimeric or mutant receptor constructs and the RE1.pGL2 luciferase reporter were co-transfected into HepG2 cells using FuGENE 6 at a DNA ratio of 4:1. The transiently transfected cells were resuspended in Dulbecco's modified Eagle's medium ϩ penicillin-streptavidin ϩ glutamate supplemented with 0.2% of AlbuMaxII and seeded into 96-well clear bottom plates at 50,000 cells/well. After 16 -18 h of serum starvation, the transfected cells were treated with or without varying concentrations of SB394725 (synthesized in-house according to the published synthetic route (18) ) or the relevant cytokine control in Me 2 SO with or without 25 M of ZnSO 4 for 5-7 h. BrightGlo was diluted to 60% and added 1:1 to the treated cells, and the plates were read on an Acquest plate reader to detect the luminescence signal. Recombinant hTpo and hG-CSF proteins were obtained from R & D Systems. The results were processed and graphed using PRIZM software (Houston, TX).
hTpoR-(479 -519) Peptide Expression and Purification-The hTpoR-(479 -519) peptide was expressed and purified according to the protocol of Park et al. (19) . Briefly, the hTpoR-(479 -519) peptide was expressed as a ketosteroid isomerase fusion protein in BLR(DE3)pLysS E. coli cells by growing the cells to A 600 nm ϭ 0.8 and then inducing with a final concentration of 1 mM isopropyl 1-thio-␤-D-galactopyranoside. The fusion peptide was purified in the inclusion bodies under denaturing conditions using immobilized metal ion affinity chromatography. The ketosteroid isomerase and His tags were cleaved using a cyanogen bromide chemical reaction, and the hTpoR-(479 -519) peptide was purified by reverse phase high performance liquid chromatography (Waters Delta 600 chromatographic system, Milford, MA) on a Delta-Pak C4 column. Solution NMR Spectroscopy-The solution NMR experiments were performed on a Bruker DRX 600 MHz spectrometer equipped with a 5-mm triple resonance cryogenic probe and z-axis gradient at a temperature of 45°C. The two-dimensional 1 H- 15 N HSQC spectra were obtained using the uniformly and selectively 15 N-labeled samples at protein concentrations of 0.3-1.0 mM. The two-dimensional 1 H-15 N heteronuclear multiple quantum coherence-nuclear Overhauser effect spectroscopy and three-dimensional 1 H-15 N nuclear Overhauser effect spectroscopy-HSQC spectra were obtained using a 250-ms mixing time. The sensitivity-enhanced in-phase and anti-phase HSQC spectra obtained on isotropic and weakly aligned samples were used to measure the 1 H- 15 N residual dipolar couplings. The NMR data were processed using the NMRPipe/ NMRDraw and NMRView programs (20 (21) was used for cross-polarization to compensate for power mismatch. Typical parameters were a 6-s recycle delay and 1-K scans with 5-10 ms of acquisition time for the onedimensional experiments. The twodimensional PISEMA spectra of uniformly 15 N-labeled samples were obtained from a total of 64 t 1 increments and 512 t 2 complex points with 128 scans for each t 1 increment. The frequency jumps (to satisfy the Lee-Goldburg off-resonance irradiation for PISEMA experiments) were 35.4 kHz. The optimal 1 H carrier position was determined experimentally to be ϳ9 ppm, which agreed with the prediction for the TM helices based on the typical position chosen for mechanically oriented bilayers parallel to the static field (ϳ3 ppm) and taking into account the 90°orientation and the bicelle order parameters.
Dipolar Wave Analysis and Structure Calculation-The experimentally measured residual dipolar couplings (RDCs) were analyzed by MATLAB software to identify helical regions as described elsewhere (22, 23) . The RDCs from the overlapped peaks were excluded for the analysis. The 1 H-15 N RDCs were fitted to sinusoids of a periodicity of 3.6 to characterize the length, curvature, relative orientation, and rotation of ␣-helices within the hTpoR-(479 -519) peptide. Unconstrained nonlinear optimization was used to fit the amplitude and phase of a sinusoid with a periodicity of 3.6, and residues were designated as a part of a continuous helix if they fitted within the average error of the measurements (0.5 Hz).
The software program X-PLOR-NIH (24) was used to calculate the three-dimensional structures from the experimental data by using a basic simulated annealing protocol. An extended template was annealed against dihedral angle restraints with a 300-kcal/K force constant in the ␣-helical regions of the hTpoR-(479 -519) peptide identified by dipolar wave fitting. As described in the rdcpot module of X-PLOR-NIH, the harmonic restraints for the 1 H-15 N RDCs were introduced with a linear increase of force constant from 0.01 to 7 kcal Hz Ϫ1 K Ϫ1 as the temperature was lowered to 25 K over 120 ps with a fixed error bound of 0.5 Hz/coupling. A P gyr potential was applied in the calculation of the hTpoR-(479 -519) peptide at a force constant of 50 kcal mol Ϫ1 Å Ϫ2 , and further optimization was performed. The accepted structures have violations of RDCs Ͻ0.5 Hz and deviation of dihedral angles Ͻ10°from those determined by dipolar wave fitting. One structural family was chosen from the accepted structures that supported the orientation of two helices as determined by solid-state NMR experiments.
RESULTS
We generated chimeric receptor constructs containing different regions of the hTpoR and hG-CSFR to identify the sequence requirements for SB394725 activity. A cellular assay based on a luciferase reporter gene construct driven by STAT response elements derived from the IRF-1 promoter (STATREluc) (3) was used to evaluate the activity of SB394725. The receptor constructs were co-transfected with the STATRE-luc plasmid into HepG2 cells, and the activity of SB394725 was measured (Fig. 1A) . The activity of SB394725 was independent of the cytoplasmic domain sequence of hTpoR as shown by the robust activation of the chimeric receptor T(T)G, whose cytoplasmic domain consisted only of the hG-CSFR sequences, specifically the N-terminal portion with the STAT3 recruitment site. Substitution of the TM domain sequence of hTpoR with that of the hG-CSFR sequence resulted in the loss of activation of the chimeric receptor T(G)G by SB394725. These results suggested that the hTpoR TM domain is either involved in interaction with SB394725 or is required for productive conformational changes induced by binding of SB394725 to hTpoR. SB394725 activated the hG-CSFR chimeric receptor (G(T)G), which contains the hTpoR TM domain and G(13 ϩ T)G, which contains 13 residues of the extracellular JMR and TM of the hTpoR in a Zn 2ϩ -dependent manner, with the G(13 ϩ T)G chimera showing an equivalent SB394725 activity as the T(T)G chimera. These data also suggested that, in addition to the TM domain residues, the 13 amino acids in the extracellular JMR of hTpoR are likely to be involved with or influenced by interaction of the receptor with SB394725.
The activity of SB394725 was reported to be specific for the human and chimpanzee TpoRs (3). It was also reported that the presence of a His residue in the TM domain of the hTpoR confers species selectivity to other hTpoR-specific small molecule ligands (4, 25) . None of the other type I cytokine receptors examined, including hG-CSFR, contains a His residue in the TM domain (Fig. 1B) . The significance of this TM domain His-499 residue in conferring SB394725 selectivity was demonstrated by the loss of activity of a mutant hTpoR containing a H499L mutation (Fig. 1C) .
Our results from the domain swap and mutagenesis studies suggested that the extracellular JMR-TM region of hTpoR plays a key role in interacting with SB394725. To understand the agonist activity of SB394725, we studied its interaction with the extracellular JMR-TM domain of hTpoR by solution and solid-state NMR using a 41-residue hTpoR-(479 -519) polypeptide, which consists of 13 extracellular JMR residues, 22 predicted TM domain residues, and 6 cytoplasmic JMR residues (Fig. 2A) . The uniformly 15 N-labeled hTpoR-(479 -519) peptide formed a homogeneous preparation in DHPC micelles (Fig. 2B) (26) . The limited dispersion of frequencies in the 1 H chemical shift dimension of the two-dimensional 1 H- 15 N HSQC spectrum suggests that the hTpoR-(479 -519) peptide comprises primarily the ␣-helix, as the TM domains of type I cytokine receptors are predicted to form a single rigid ␣-helical structure (27) . The predicted ␣-helix of the hTpoR TM domain starts from Ile-492 and ends at Leu-512 ( Fig. 2A) . Surprisingly, two distinct ␣-helical regions were identified from dipolar waves that mapped the RDCs measured from the in-phase and anti-phase HSQC experiments (Fig. 2B) (28, 29) . The first 7-residue amphipathic helix (Thr-487 to Ser-493) may be somewhat more mobile than the second and is connected to the second 18-residue hydrophobic helix (Thr-496 to Leu-513) by a few non-helical residues. The first four predicted TM domain residues Ile-492-Val-495 were outside the second hydrophobic helix, with residues Ile-492 and Ser-493 located at the C terminus of the first amphipathic helix and residues Leu-494 and Val-495 at the interhelical region (Fig. 2C) .
Solid-state NMR spectra of magnetically aligned bicelle samples were used to characterize the relative orientations of the amphipathic and hydrophobic helices of the hTpoR-(479 -519) peptide. The hTpoR-(479 -519) peptide was well aligned in bicelles (Fig. 3A) , and the one-dimensional 15 N NMR spectrum of uniformly 15 N-labeled hTpoR-(479 -519) peptide in the parallel bicelles (30) showed a clear separation of two distinct bands of resonances (Fig. 3A) . The frequencies of the resonances observed in both one-dimensional and two-dimensional spectra were consistent with the simulated spectra (Fig.  3B) . Resonances from residues in the hydrophobic TM helix occur between 160 and 200 ppm, and those between 80 and 100 ppm are associated with residues in an in-plane amphipathic helix oriented nearly parallel to the membrane surface. The resonance intensity near the isotropic frequency (120 ppm) is likely from the unstructured residues at the N and C termini of the polypeptide. The two-dimensional experimental PISEMA spectrum (Fig. 3C ) of the uniformly 15 N-labeled hTpoR-(479 -519) peptide has resonances in the region (85-105 ppm) expected for a hydrophobic transmembrane helix with an ϳ28°t ilt angle, which is consistent with the value predicted by the hydrophobic mismatch with the lipids (30, 31) . Fig. 3D is a structural model of the hTpoR-(479 -519) peptide based on the NMR data shown in Figs. 2 and 3 . The two-dimensional 1 H-15 N HSQC spectra enabled the identification of residues that are affected by binding to SB394725. The superimposed 1 H-15 N HSQC spectra of the uniformly 15 N-labeled hTpoR-(479 -519) peptide with and without SB394725 are shown in Fig. 4A . Binding of SB394725 affected the resonance assigned to His-499 most significantly as shown from the chemical shift changes induced by SB394725 addition (Fig. 4B) . In addition to His-499, residues Glu-484, Ser-493, Leu-494, Thr-496, Val-501, Leu-504, Ala-506, Gly-509, and Leu-511 were also affected to varying degrees upon SB394725 addition. Titration of SB394725 induced gradual changes in chemical shift of the residues affected, indicating that the changes observed are induced specifically by the hTpoR-(479 -519) peptide binding to SB394725 (data not shown).
The NMR data indicated that His-499 and several residues in the extracellular JMR-TM region of hTpoR play a key role in interacting with SB394725. To further confirm the results, we performed an alanine-scanning mutagenesis study of residues in the extracellular JMR-TM region of hTpoR using the STATRE-luc reporter gene assay. Each alanine mutant receptor was tested for response to both SB394725 and recombinant hTpo. Because hTpo interacts specifically with the extracellular domain of hTpoR, alanine substitution in the extracellular JMR-TM region of hTpoR should not affect binding of hTpo to alanine mutant hTpoRs that expressed and folded properly on the cell surface. The results from alanine scanning were presented in Fig. 4 , C (SB394725 treatment) and D (Tpo treatment). The residues sensitive to alanine substitution are Thr-485, Glu-488, Trp-491, Ile-492, Leu-494, Val-495, Leu-498, His-499, Leu-500, Leu-504, Val-507, and Leu-508. Alanine substitution of residues Thr-485, Glu-488, Trp-491, Leu-498, and Leu-508 affected activities of both SB394725 and hTpo, indicating that these residues were most likely involved in maintaining the expression levels and/or structural integrity of the hTpoR. Consequently, the results of alanine-scanning mutagenesis indicated that Ile-492, Leu-494, His-499, Leu-500, Leu-504, and Val-507 are the residues involved in interaction with SB394725.
Based on the NMR data, alanine-scanning results, and the physicochemical characteristics of SB394725, we concluded that residues involved in interaction with SB394725 were located at the extracellular JMR, the interhelical region, and the N terminus of the TM domain helix. A schematic diagram showing interaction between SB394725 and the hTpoR-(479 -519) peptide is presented in Fig. 4E .
Because SB394725 showed strong Zn 2ϩ -dependent activity in the luciferase reporter assay, we attempted to map Zn 2ϩ -coordinating sites in the hTpoR-(479 -519) peptide by identifying chemical shift perturbations in the two-dimensional 1 H-15 N HSQC spectra upon Zn 2ϩ addition. Zn 2ϩ addition affected only residues Ile-492, Ser-493, and His-499 significantly (data not shown). The addition of SB394725 to the peptide-Zn 2ϩ complex induced additional resonance shifts, most notably Ile-492, Ser-493, Thr-496, His-499, and a few other C-terminal TM domain residues. 
DISCUSSION
Cytokines are known to activate their respective cell-surface receptor by binding and interacting specifically with the extracellular domain of the receptor. Here we have shown that residues in the extracellular JMR-TM region of hTpoR play a crucial role in the interaction with a small molecule Tpo mimic. The unexpected role that the TM domain played in direct interaction with SB394725 and mediating hTpoR activation is consistent with previous studies suggesting that the TM domain of several cytokine receptors may be involved in ligand-independent receptor dimerization and could also play a key role in mediating receptor activation (7, (13) (14) (15) (16) (17) .
The hTpoR extracellular JMR-TM peptide unexpectedly comprises two ␣-helices separated by a few non-helical residues. Kubatsky et al. reported that the first few residues of the predicted TM domain of EpoR form ␣-helix cap (27) . Consistent with their observation, Ile-492-Val-495 (the first four predicted TM residues of hTpoR) were outside the predicted hydrophobic TM helix. However, instead of formation of a helix cap, our NMR data show that the extracellular JMR of hTpoR contains a short seven-residue amphipathic helix and that the first two predicted TM residues Ile-492 and Ser-493 are a part of the amphipathic helix. We observed that binding of Zn 2ϩ and SB394725 to the hTpoR-(479 -519) peptide affected the resonances of Ile-492, Ser-493, and His-499. Interestingly, cysteine substitution of residues analogous to Ile-492 and Ser-493 in mEpoR (Leu-226 and Ile-227, respectively) was reported to result in presumed disulfide bond-mediated, constitutively active mEpoR (15) . The collective information suggests that binding of SB394725 to hTpoR presumably brings two extracellular JMR-TM peptides into an active orientation involving residues Ile-492 and Ser-493 and is possibly facilitated by conformational flexibility of the non-helical residues located between the two ␣-helices.
His-499 was identified as a key residue in determining the selective interaction between SB394725 and hTpoR as shown by mutagenesis studies and NMR experiments (Figs. 1 and 4) . Interestingly, His-499 is not required by Tpo-induced TpoR activation (Fig. 4) , indicating that His-499 is not an essential residue for the formation of a conformationally active dimeric receptor. Zn 2ϩ addition induced a selective chemical shift perturbation of His-499, an amino acid with a known propensity for metal binding. Because SB394725 showed strong Zn 2ϩ -dependent activity, our data indicates that SB394725 presumably binds to hTpoR through Zn 2ϩ -mediated interaction with His-499. More detailed biophysical and chemical studies will be required to determine the exact stoichiometry of the SB394725⅐Zn 2ϩ ⅐His-499 complex and the binding affinity of SB394725 to the extracellular JMR-TM peptide in the presence and absence of Zn 2ϩ . The NMR results showed that the addition of SB394725 induced chemical shift perturbations of the C-terminal residues of the TM domain. Because SB394725 contains a sulfonic acid moiety, it is unlikely that this charged molecule could move deeply into the highly hydrophobic TM environment. This is consistent with modeling information obtained from molecular docking of SB394725 to the hTpoR-(479 -519) peptide, indicating that no significant interactions at the C terminus of the TM domain of hTpoR occurred (data not shown). Therefore, the chemical shift perturbations of the C-terminal residues Leu-504, Ala-506, Gly-509, and Leu-511-Leu-513 induced by the addition of SB394725 were most likely the result of conformational changes induced by the binding of SB394725 as opposed to direct interactions with SB394725.
Taken together, our data, for the first time, provide detailed biophysical information on ligand-induced movement of cytokine receptor extracellular JMR-TM region residues and thus offer valuable insight into both the distinctive mechanism of action of SB394725 and the general mechanism of cytokine receptor activation.
